PINE Study
Key features:
- One of the largest incidence cohorts worldwide (201 patients with Parkinson's disease, 114 with other forms of parkinsonism)
- Derived from incidence study with high consent rate to follow-up (94%) resulting in a population-representative cohort
- Very few losses to follow-up (e.g. >99% ascertainment of death and dementia)
- Participants are seen annually (at home if needed)
- Carer and matched control cohorts
- Wide range of demographic, clinical, genetic, and imaging data
- High rate of pathological diagnostic confirmation